ArticleMiddle East African journal of ophthalmology
Intravitreal Aflibercept for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome.
Article in Middle East African journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- When the Air Gets Thin, and the Blood Gets Thick: Choroidal Hemangioma in High-Altitude Polycythemia.Cureus · 2026Article
- Advancing Non-Invasive Ophthalmic Imaging in Sturge-Weber Syndrome: Clinical Guidelines Towards Early Choroidal Hemangioma Detection.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 16-year-old female with Sturge-Weber syndrome (SWS) presented with decreased vision in the left eye (20/100). Examination and multimodal imaging showed diffuse choroidal hemangioma with choroidal neovascularization and macular edema. Treatment with three monthly injections of intravitreal aflibercept improved vision by 4 lines with complete resolution of the macular edema sustained 4 months after the last injection. A review of the literature showed that this is the first report of successful use of aflibercept to treat macular edema and choroidal neovascularization associated with diffuse choroidal hemangioma in SWS. We suggest that early antivascular endothelial growth factor injections should be considered when faced with choroidal neovascularization associated with diffuse choroidal hemangiomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.